Beneficial Effects of Combined AT(1) Receptor/Neprilysin Inhibition (ARNI) Versus AT(1) Receptor Blockade Alone in the Diabetic Eye

PURPOSE: Dysfunction of the renin-angiotensin system (RAS) contributes to pathogenesis of diabetic retinopathy (DR). Yet RAS blockers have only limited beneficial effects on progression of DR in clinical trials. The natriuretic peptide system offsets RAS, so that enhancing the activity of this syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Tuhina, Roksnoer, Lodi C. W., Zhu, Ping, Verma, Amrisha, Li, Yiming, Batenburg, Wendy W., de Vries, René, Danser, A. H. Jan, Li, Qiuhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2016
Materias:
Physiology and Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156511/
https://www.ncbi.nlm.nih.gov/pubmed/27951594
http://dx.doi.org/10.1167/iovs.16-20289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156511/
https://www.ncbi.nlm.nih.gov/pubmed/27951594
http://dx.doi.org/10.1167/iovs.16-20289

Ejemplares similares